Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00369070
Status:
TERMINATED
Last Update Posted:
2018-01-04
First Post:
2006-08-24
Brief Title:
A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC
Sponsor:
Organization:
Amgen